Skip to Content

1,563 Results Found

  • Article
  • Open Access
8 Citations
5,696 Views
13 Pages

Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms

  • Sandra A. Reza-López,
  • Susana González-Gurrola,
  • Oscar O. Morales-Morales,
  • Janette G. Moreno-González and ,
  • Ana M. Rivas-Gómez,
  • Everardo González-Rodríguez,
  • Verónica Moreno-Brito,
  • Angel Licón-Trillo and
  • Irene Leal-Berumen
  • + 4 authors+ 0 author

14 December 2023

Glucose and lipid metabolism regulation by the peroxisome proliferator-activated receptors (PPARs) has been extensively reported. However, the role of their polymorphisms remains unclear. Objective: To determine the relation between PPAR-γ2 rs1...

(This article belongs to the Special Issue PPARs as Key Regulators in Different Diseases)
  • Article
  • Open Access
13 Citations
3,966 Views
18 Pages

Pro12Ala PPAR-γ2 and +294T/C PPAR-δ Polymorphisms and Association with Metabolic Traits in Teenagers from Northern Mexico

  • Martín A. Carrillo-Venzor,
  • Nancy R. Erives-Anchondo,
  • Janette G. Moreno-González,
  • Verónica Moreno-Brito and ,
  • Angel Licón-Trillo,
  • Everardo González-Rodríguez,
  • Pilar del Carmen Hernández-Rodríguez,
  • Sandra A. Reza-López,
  • Verónica Loera-Castañeda and
  • Irene Leal-Berumen
  • + 5 authors+ 0 author

10 July 2020

Peroxisome proliferator-activated receptors (PPARs) play roles in glucose and lipid metabolism regulation. Pro12Ala PPAR-γ2 and +294T/C PPAR-δ have been associated with dyslipidemia, hyperglycemia and high body mass index (BMI). We compar...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Review
  • Open Access
103 Citations
14,532 Views
22 Pages

PPAR-Mediated Toxicology and Applied Pharmacology

  • Yue Xi,
  • Yunhui Zhang,
  • Sirui Zhu,
  • Yuping Luo and ,
  • Pengfei Xu and
  • Zhiying Huang
  • + 1 author+ 0 author

3 February 2020

Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptor family, attract wide attention as promising therapeutic targets for the treatment of multiple diseases, and their target selective ligands were also intensiv...

(This article belongs to the Special Issue The Role of PPARs in Disease)
  • Review
  • Open Access
27 Citations
6,094 Views
15 Pages

Potential Therapeutic Effects of PPAR Ligands in Glioblastoma

  • Rossella Basilotta,
  • Marika Lanza,
  • Giovanna Casili,
  • Giulia Chisari and ,
  • Stefania Munao,
  • Lorenzo Colarossi,
  • Laura Cucinotta,
  • Michela Campolo,
  • Emanuela Esposito and
  • Irene Paterniti
  • + 5 authors+ 0 author

10 February 2022

Glioblastoma (GB), also known as grade IV astrocytoma, represents the most aggressive form of brain tumor, characterized by extraordinary heterogeneity and high invasiveness and mortality. Thus, a great deal of interest is currently being directed to...

(This article belongs to the Special Issue The Role of PPARs in Disease II)
  • Review
  • Open Access
506 Citations
23,874 Views
15 Pages

PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice

  • Yaping Wang,
  • Takero Nakajima,
  • Frank J. Gonzalez and
  • Naoki Tanaka

Peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ modulate lipid homeostasis. PPARα regulates lipid metabolism in the liver, the organ that largely controls whole-body nutrient/energy homeostasis, and its ab...

(This article belongs to the Special Issue PPARs in Metabolic Regulation: Implications for Health and Disease)
  • Article
  • Open Access
9 Citations
3,471 Views
22 Pages

PPAR-α Insufficiency Enhances Doxorubicin-Induced Nephropathy in PPAR-α Knockout Mice and a Murine Podocyte Cell Line

  • Kohei Matsuta,
  • Kazuko Kamiyama,
  • Toru Imamoto,
  • Izumi Takeda and ,
  • Shinya Masunaga,
  • Mamiko Kobayashi,
  • Naoki Takahashi,
  • Kenji Kasuno,
  • Masanori Hara and
  • Hideki Kimura
  • + 7 authors+ 2 authors

28 August 2024

Peroxisome proliferator-activated receptor-alpha (PPAR-α) and its exogenous activators (fibrates) promote autophagy. However, whether the deleterious effects of PPAR-α deficiency on doxorubicin (DOX)-induced podocytopathy are associated w...

(This article belongs to the Special Issue The Role of PPARs in Disease - Volume III)
  • Review
  • Open Access
61 Citations
8,699 Views
17 Pages

Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases

  • Zaza Khuchua,
  • Aleksandr I. Glukhov,
  • Arnold W. Strauss and
  • Sabzali Javadov

4 November 2018

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that bind to DNA and regulate transcription of genes involved in lipid and glucose metabolism. A growing number of studies provide strong evidence that PPARs are the pr...

(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
  • Review
  • Open Access
233 Citations
24,623 Views
21 Pages

PPAR Agonists and Metabolic Syndrome: An Established Role?

  • Margherita Botta,
  • Matteo Audano,
  • Amirhossein Sahebkar,
  • Cesare R. Sirtori and ,
  • Nico Mitro and
  • Massimiliano Ruscica
  • + 1 author+ 0 author

Therapeutic approaches to metabolic syndrome (MetS) are numerous and may target lipoproteins, blood pressure or anthropometric indices. Peroxisome proliferator-activated receptors (PPARs) are involved in the metabolic regulation of lipid and lipoprot...

(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
  • Review
  • Open Access
33 Citations
8,009 Views
36 Pages

14 December 2021

Peroxisome proliferator-activated receptors (PPAR-γ, PPAR-α, and PPAR-β/δ) are ligand-dependent nuclear receptors that play a critical role in the regulation of hundreds of genes through their activation. Their expression and t...

(This article belongs to the Topic Bioactive Natural Products and Synthetic Small Molecules as Potential Investigational Treatments for Neurodegenerative Diseases)
  • Review
  • Open Access
61 Citations
7,582 Views
12 Pages

23 April 2019

Peroxisome proliferator-activated receptors (PPARs) are part of the nuclear hormone receptors superfamily that plays a pivotal role in functions such as glucose and lipid homeostasis. Astaxanthin (ASX) is a lipid-soluble xanthophyll carotenoid synthe...

(This article belongs to the Special Issue Astaxanthin: A Potential Therapeutic Agent)
  • Communication
  • Open Access
15 Citations
7,871 Views
10 Pages

Synthesis of Phthalimide Derivatives as Potential PPAR-γ Ligands

  • So Hyeon Eom,
  • Sen Liu,
  • Mingzhi Su,
  • Tae Hwan Noh and ,
  • Jongki Hong,
  • Nam Deuk Kim,
  • Hae Young Chung,
  • Min Hye Yang and
  • Jee H. Jung
  • + 4 authors+ 0 author

8 June 2016

Paecilocin A, a phthalide derivative isolated from the jellyfish-derived fungus Paecilomyces variotii, activates PPAR-γ (Peroxisome proliferator-activated receptor gamma) in rat liver Ac2F cells. Based on a SAR (Structure-activity relationships) stud...

  • Article
  • Open Access
23 Citations
5,816 Views
18 Pages

Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach

  • Hyo Jin Gim,
  • Yong-Sung Choi,
  • Hua Li,
  • Yoon-Jung Kim and ,
  • Jae-Ha Ryu and
  • Raok Jeon
  • + 1 author+ 0 author

4 October 2018

Peroxisome proliferator-activated receptors (PPARs) are important targets in metabolic diseases including obesity, metabolic syndrome, diabetes, and non-alcoholic fatty liver disease. Recently, they have been highlighted as attractive targets for the...

(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
  • Review
  • Open Access
121 Citations
13,494 Views
20 Pages

Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

  • Joost Boeckmans,
  • Alessandra Natale,
  • Matthias Rombaut,
  • Karolien Buyl and ,
  • Vera Rogiers,
  • Joery De Kock,
  • Tamara Vanhaecke and
  • Robim M. Rodrigues
  • + 3 authors+ 0 author

21 December 2019

Non-alcoholic fatty liver disease (NAFLD) affects one-third of the population worldwide, of which a substantial number of patients suffer from non-alcoholic steatohepatitis (NASH). NASH is a severe condition characterized by steatosis and concomitant...

(This article belongs to the Special Issue Recent Advances in Liver Repair Strategies)
  • Review
  • Open Access
5 Citations
10,947 Views
12 Pages

30 June 2022

The Peroxisome proliferator-activated receptors (PPARs) play vital roles in regulating cellular differentiation, proliferation, and caspase-mediated cell death pathways. They are regarded as promising targets for anti-tumor drug development, particul...

  • Article
  • Open Access
6 Citations
4,588 Views
17 Pages

PPAR-γ Inhibits Chronic Apical Periodontitis by Facilitating Macrophage Efferocytosis

  • Yuting Wang,
  • Mingfei Wang,
  • Xiaowen Jia,
  • Yifei Tang and ,
  • Jiayi Wang,
  • Wenjiao Zhang,
  • Tiezhou Hou and
  • Xiaoyue Guan
  • + 3 authors+ 0 author

19 October 2025

This study aimed to elucidate the role of peroxisome proliferator-activated receptor-γ (PPAR-γ) in regulating macrophage efferocytosis during the pathogenesis of chronic apical periodontitis (CAP). Clinical specimens, rat periapical lesio...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
16 Citations
8,219 Views
14 Pages

Synthesis of PPAR-γ Activators Inspired by the Marine Natural Product, Paecilocin A

  • Bin Xiao,
  • Mingzhi Su,
  • Eun La Kim,
  • Jongki Hong and ,
  • Hae Young Chung,
  • Hyung Sik Kim,
  • Jun Yin and
  • Jee H. Jung
  • + 3 authors+ 0 author

13 February 2014

A series of N-substituted phthalimide derivatives were synthesized based on a pharmacophore study of paecilocin A (a natural PPAR-γ agonist) and synthetic leads. The introduction of hydrophilic and hydrophobic groups to the phthalimide skeleton yield...

  • Review
  • Open Access
107 Citations
17,456 Views
17 Pages

The prevalence of obesity and atherosclerosis has substantially increased worldwide over the past several decades. Peroxisome proliferator-activated receptors (PPARs), as fatty acids sensors, have been therapeutic targets in several human lipid metab...

(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
  • Review
  • Open Access
105 Citations
22,847 Views
15 Pages

29 April 2020

The cytokine storm is an abnormal production of inflammatory cytokines, due to the over-activation of the innate immune response. This mechanism has been recognized as a critical mediator of influenza-induced lung disease, and it could be pivotal for...

(This article belongs to the Section Natural Products Chemistry)
  • Review
  • Open Access
1 Citations
771 Views
31 Pages

31 July 2026

Peroxisome proliferator-activated receptors (PPARα, PPARβ/δ, and PPARγ) are ligand-regulated nuclear receptors that coordinate lipid metabolism, glucose homeostasis, inflammation, adipogenesis, differentiation, and disease-asso...

(This article belongs to the Special Issue The Role of PPARs in Disease - Volume IV)
  • Article
  • Open Access
8 Citations
4,767 Views
11 Pages

Influence of Single-Nucleotide Polymorphisms in PPAR-δ, PPAR-γ, and PRKAA2 on the Changes in Anthropometric Indices and Blood Measurements through Exercise-Centered Lifestyle Intervention in Japanese Middle-Aged Men

  • Yuichiro Nishida,
  • Minako Iyadomi,
  • Hirotaka Tominaga,
  • Hiroaki Taniguchi and ,
  • Yasuki Higaki,
  • Hiroaki Tanaka,
  • Mikako Horita,
  • Chisato Shimanoe,
  • Megumi Hara and
  • Keitaro Tanaka
  • + 5 authors+ 0 author

The purpose of the current study was to examine the influence of single-nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor-δ (PPAR-δ), PPAR-γ, and α2 isoforms of the catalytic subunit of AMP-activated protein kinase (PR...

(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
  • Article
  • Open Access
25 Citations
6,659 Views
14 Pages

A Molecular Dynamics Approach to Explore the Intramolecular Signal Transduction of PPAR-α

  • Shaherin Basith,
  • Balachandran Manavalan,
  • Tae Hwan Shin and
  • Gwang Lee

Dynamics and functions of the peroxisome proliferator-activated receptor (PPAR)-α are modulated by the types of ligands that bind to the orthosteric sites. While several X-ray crystal structures of PPAR-α have been determined in their ago...

(This article belongs to the Special Issue Protein Structural Dynamics 2019)
  • Article
  • Open Access
8 Citations
3,323 Views
22 Pages

Involvement of Nuclear Receptors PPAR-α, PPAR-γ, and the Transcription Factor Nrf2 in Cellular Protection Against Oxidative Stress Regulated by H2S and Induced by Hypoxia–Reoxygenation and High Glucose in Primary Cardiomyocyte Cultures

  • Luz Ibarra-Lara,
  • Araceli Sánchez-López,
  • Leonardo del Valle-Mondragon,
  • Elizabeth Soria-Castro and ,
  • Gabriela Zarco-Olvera,
  • Mariana Patlán,
  • Verónica Guarner-Lans,
  • Juan Carlos Torres-Narváez,
  • Angélica Ruiz-Ramírez and
  • Vicente Castrejón-Téllez
  • + 7 authors+ 2 authors

Myocardial oxidative stress increases under conditions of hyperglycemia and ischemia/reperfusion (I/R) injury, leading to cellular damage. Inhibition of oxidative stress is involved in the cardioprotective effects of hydrogen sulfide (H2S) during I/R...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Review
  • Open Access
7 Citations
5,110 Views
53 Pages

PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications

  • Vladimir Sobolev,
  • Ekaterina Tchepourina,
  • Anna Soboleva,
  • Elena Denisova and ,
  • Irina Korsunskaya and
  • Alexandre Mezentsev
  • + 1 author+ 0 author

2 April 2025

Changes in skin pigmentation, like hyperpigmentation or moles, can affect appearance and social life. Unlike locally containable moles, malignant melanomas are aggressive and can spread rapidly, disproportionately affecting younger individuals with a...

(This article belongs to the Section Cellular Pathology)
  • Article
  • Open Access
12 Citations
3,989 Views
20 Pages

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors

  • Leonardo Brunetti,
  • Antonio Carrieri,
  • Luca Piemontese,
  • Paolo Tortorella and ,
  • Fulvio Loiodice and
  • Antonio Laghezza
  • + 1 author+ 0 author

24 September 2020

In recent years, Peroxisome Proliferator-Activated Receptors (PPARs) have been connected to the endocannabinoid system. These nuclear receptors indeed mediate the effects of anandamide and similar substances such as oleoyl-ethanolamide and palmitoyl-...

(This article belongs to the Special Issue Exploiting the Multitarget and Repositioned Drugs Approach)
  • Review
  • Open Access
9 Citations
3,570 Views
26 Pages

Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment

  • Hung Thai Vu,
  • Vien Duc Nguyen,
  • Hiroko Ikenaga and
  • Tsutomu Matsubara

Metabolic dysfunction-associated steatotic liver disease/steatohepatitis (MASLD/MASH) is a major disease worldwide whose effective treatment is challenging. Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamil...

(This article belongs to the Section Cell Biology and Pathology)
  • Review
  • Open Access
187 Citations
26,941 Views
14 Pages

The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor

  • Yi Liu,
  • Jennifer K. Colby,
  • Xiangsheng Zuo,
  • Jonathan Jaoude and ,
  • Daoyan Wei and
  • Imad Shureiqi
  • + 1 author+ 0 author

26 October 2018

Peroxisome proliferator-activated receptor-delta (PPAR-δ), one of three members of the PPAR group in the nuclear receptor superfamily, is a ligand-activated transcription factor. PPAR-δ regulates important cellular metabolic functions tha...

(This article belongs to the Special Issue PPARs in Cellular and Whole Body Energy Metabolism)
  • Review
  • Open Access
57 Citations
7,440 Views
39 Pages

The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells

  • Vladimir V. Sobolev,
  • Ekaterina Tchepourina,
  • Irina M. Korsunskaya,
  • Natalia A. Geppe and ,
  • Svetlana N. Chebysheva,
  • Anna G. Soboleva and
  • Alexandre Mezentsev
  • + 2 authors+ 0 author

26 August 2022

The peroxisome proliferator-activated receptor PPAR-γ is one of three PPAR nuclear receptors that act as ligand-activated transcription factors. In immune cells, the skin, and other organs, PPAR-γ regulates lipid, glucose, and amino acid...

(This article belongs to the Special Issue Recent Advances in Skin Disease and Comorbidities)
  • Article
  • Open Access
1,210 Views
20 Pages

Chiglitazar Activates PPAR-α/γ to Suppress Oxidative Stress and Angiogenesis in Corneal Neovascularization

  • Tao Tao,
  • Jiyuan Ye,
  • Ruifeng Li,
  • Yan Ke and ,
  • Xiaoqin Zheng,
  • Qinghe Zhang,
  • Lan Zheng,
  • Shuwen Wang,
  • Zhen Zhang and
  • Cheng Li
  • + 6 authors+ 1 author

Purpose: Chiglitazar (Chi) is a pan-peroxisome proliferator-activated receptor (PPAR) agonist with reported anti-oxidative effects in metabolic disorders. In this study, we investigate its therapeutic effects and potential mechanisms in corneal neova...

(This article belongs to the Topic Cell Signaling and Redox Biology: From Molecular Mechanisms to Therapeutic Applications)
  • Article
  • Open Access
30 Citations
4,696 Views
21 Pages

Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling

  • Alessia Filippone,
  • Giovanna Casili,
  • Sarah Adriana Scuderi,
  • Deborah Mannino and ,
  • Marika Lanza,
  • Michela Campolo,
  • Irene Paterniti,
  • Anna Paola Capra,
  • Cristina Colarossi and
  • Emanuela Esposito
  • + 8 authors+ 3 authors

29 December 2022

New therapeutic approaches are needed to improve the outcome of patients with glioblastoma (GBM). Propionate, a short-chain fatty acid (SCFA), has a potent antiproliferative effect on various tumor cell types. Peroxisome proliferator-activated recept...

(This article belongs to the Special Issue The Role of Autophagy in Brain Tumors)
  • Review
  • Open Access
42 Citations
8,760 Views
14 Pages

10 September 2021

The peroxisome proliferator-activated receptor (PPAR) family of transcription factors has been demonstrated to play critical roles in regulating fuel selection, energy expenditure and inflammation in skeletal muscle and other tissues. Activation of P...

(This article belongs to the Special Issue PPARs as Key Mediators of Metabolic and Inflammatory Regulation)
  • Article
  • Open Access
14 Citations
4,536 Views
11 Pages

11,12-EET Regulates PPAR-γ Expression to Modulate TGF-β-Mediated Macrophage Polarization

  • Xiaoming Li,
  • Sebastian Kempf,
  • Stefan Günther,
  • Jiong Hu and
  • Ingrid Fleming

23 February 2023

Macrophages are highly plastic immune cells that can be reprogrammed to pro-inflammatory or pro-resolving phenotypes by different stimuli and cell microenvironments. This study set out to assess gene expression changes associated with the transformin...

(This article belongs to the Special Issue The Role of Inflammation in Atherosclerosis and Coronary Artery Disease)
  • Review
  • Open Access
74 Citations
9,172 Views
17 Pages

Modulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets

  • J. Abraham Domínguez-Avila,
  • Gustavo A. González-Aguilar,
  • Emilio Alvarez-Parrilla and
  • Laura A. De la Rosa

Peroxisome proliferator-activated receptors (PPAR) are transcription factors that modulate energy metabolism in liver, adipose tissue and muscle. High fat diets (HFD) can negatively impact PPAR expression or activity, favoring obesity, dyslipidemia,...

(This article belongs to the Special Issue Linking Nutrition and Energy Metabolism: Roles of PPARs in Healthy and in Disrupted Metabolic Homeostasis)
  • Review
  • Open Access
21 Citations
7,540 Views
13 Pages

1 September 2021

The slow rate of neuronal regeneration that follows peripheral nerve repair results in poor recovery, particularly where reinnervation of muscles is delayed, leading to atrophy and permanent loss of function. There is a clear clinical need to develop...

(This article belongs to the Section Biomacromolecules: Nucleic Acids)
  • Article
  • Open Access
7 Citations
2,748 Views
15 Pages

27 October 2022

Our previous study demonstrated that peroxisome proliferator-activated receptor (PPAR) agonists downregulated cereblon (CRBN) expression and reduced the anti-myeloma activity of lenalidomide in vitro and in vivo. We aimed to determine whether DNA met...

  • Review
  • Open Access
66 Citations
12,407 Views
34 Pages

PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer

  • Sangeeta Ballav,
  • Bini Biswas,
  • Vishal Kumar Sahu,
  • Amit Ranjan and
  • Soumya Basu

13 October 2022

Peroxisome proliferator-activated receptor-γ (PPAR-γ) has emerged as one of the most extensively studied transcription factors since its discovery in 1990, highlighting its importance in the etiology and treatment of numerous diseases inv...

(This article belongs to the Special Issue The Role of PPARs in Disease II)
  • Article
  • Open Access
22 Citations
7,618 Views
16 Pages

A patented organotin di-n-butyl-di-(4-chlorobenzohydroxamato)tin (DBDCT) with high a antitumor activity was designed, however, its antitumor and toxic mechanisms have not yet been clearly illustrated. Hepatic proteins of DBDCT-treated rats were ident...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
20 Citations
4,048 Views
16 Pages

A Double-Negative Feedback Interaction between miR-21 and PPAR-α in Clear Renal Cell Carcinoma

  • Marine Goujon,
  • Justine Woszczyk,
  • Kelly Gaudelot,
  • Thomas Swierczewski and ,
  • Sandy Fellah,
  • Jean-Baptiste Gibier,
  • Isabelle Van Seuningen,
  • Romain Larrue,
  • Christelle Cauffiez and
  • Michaël Perrais
  • + 8 authors+ 3 authors

4 February 2022

Clear cell renal cell carcinoma (ccRCC) is the main histotype of kidney cancer, which is typically highly resistant to conventional therapies and known for abnormal lipid accumulation. In this context, we focused our attention on miR-21, an oncogenic...

  • Article
  • Open Access
47 Citations
10,801 Views
12 Pages

The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist

  • Mingzhi Su,
  • Jiafu Cao,
  • Jin Huang,
  • Sen Liu and ,
  • Dong Soon Im,
  • Jin-Wook Yoo and
  • Jee H. Jung
  • + 2 authors+ 0 author

4 January 2017

Previously, the authors found that 4-hydroxy-2-(4-hydroxyphenethyl) isoindoline-1,3-dione (PD1) (a phthalimide analogue) bound to and activated peroxisome proliferator-activated receptor-γ (PPAR-γ). Since PPAR-γ suppresses inflammatory responses, the...

  • Review
  • Open Access
72 Citations
11,801 Views
35 Pages

PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients

  • Naomi F. Lange,
  • Vanessa Graf,
  • Cyrielle Caussy and
  • Jean-François Dufour

Peroxisome proliferator-activated receptors (PPAR), ligand-activated transcription factors of the nuclear hormone receptor superfamily, have been identified as key metabolic regulators in the liver, skeletal muscle, and adipose tissue, among others....

(This article belongs to the Special Issue PPARs as Key Mediators of Metabolic and Inflammatory Regulation)
  • Brief Report
  • Open Access
1,736 Views
14 Pages

PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats

  • Yuyang Hao,
  • Lu Yao,
  • Yuxin Jin,
  • Sheng Yin and ,
  • Zhiwei He and
  • Huilian Che
  • + 1 author+ 0 author

16 February 2026

Background/Objectives: Food allergy-induced intestinal inflammation can impair lactose digestion and absorption by damaging the epithelium, leading to secondary lactase deficiency with no effective treatments. The immunometabolism nuclear receptor PP...

(This article belongs to the Special Issue Food Intake and Inflammatory Bowel Disease)
  • Article
  • Open Access
115 Views
19 Pages

PPAR-β/δ Is Required for Metabolic and Inflammatory Adaptation to Glucose Restriction in T98G Glioblastoma Cells

  • Laura Vargas,
  • Andres Cuellar-Quimbaya,
  • Katherine García,
  • Adriana Puerta and ,
  • Luz Norela Correa,
  • Monica Losada-Barragán and
  • Karina Vargas-Sánchez
  • + 2 authors+ 0 author

13 November 2026

Background: Glioblastoma (GBM) shows marked metabolic plasticity and resistance to conventional therapies, which has motivated the search for adjunctive metabolic strategies. Medium-chain fatty acids (MCFAs) are candidate metabolic modulators, but th...

(This article belongs to the Topic Applications of Biomedical Technology and Molecular Biological Approach in Brain Diseases, 2nd Edition)
  • Article
  • Open Access
11 Citations
4,897 Views
15 Pages

Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone

  • Jessica C. Gaspar,
  • Bright N. Okine,
  • Alvaro Llorente-Berzal,
  • Michelle Roche and
  • David P. Finn

24 February 2020

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors with three isoforms (PPARα, PPARβ/δ, PPARγ) and can regulate pain, anxiety, and cognition. However, their role in conditioned fear and pain-fear interact...

(This article belongs to the Special Issue Role of Cannabinoids in Inflammation)
  • Review
  • Open Access
573 Views
15 Pages

14 July 2026

Metabolic diseases are characterized by a complex interplay between metabolic dysregulation and chronic low-grade inflammation. Fetuin-A (FetA), a liver-derived hepatokine, has emerged as a key mediator linking these processes through its pro-inflamm...

(This article belongs to the Special Issue The Role of PPARs in Disease - Volume IV)
  • Review
  • Open Access
40 Citations
6,016 Views
22 Pages

12 May 2020

Targeting peroxisome proliferator-activated receptors (PPARs) has received increasing interest as a potential strategy to treat substance use disorders due to the localization of PPARs in addiction-related brain regions and the ability of PPAR ligand...

(This article belongs to the Special Issue The Role of PPARs in Disease)
  • Systematic Review
  • Open Access
6 Citations
2,667 Views
21 Pages

A Systematic Review of Clinical and Experimental Periodontitis Studies Demonstrating the Expression of PPAR-Gamma: A Meta-Analysis and Bioinformatics Approach

  • Marco Antonio Rimachi Hidalgo,
  • François Isnaldo Dias Caldeira,
  • Silvana Regina Perez Orrico,
  • Fabio Renato Manzolli Leite and
  • Raquel Mantuaneli Scarel-Caminaga

Aim: Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) plays important anti-inflammatory roles, including in periodontitis. This systematic review with a meta-analysis compiles evidence on the transcriptional and translational levels of...

(This article belongs to the Special Issue Molecular Mechanisms and Therapeutic Approaches for Oral Disorders)
  • Article
  • Open Access
6 Citations
2,744 Views
18 Pages

13 October 2022

In this study, we used PCR to measure the levels of the peroxisome proliferator activated receptor genes PPARα1, PPARα2, PPARβ, and PPARγ in the intestine, liver, gill, heart, kidney, brain, muscle, spleen, skin, and stomach of...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
7 Citations
3,234 Views
17 Pages

Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma

  • Patrizia Leone,
  • Antonio Giovanni Solimando,
  • Marcella Prete,
  • Eleonora Malerba and ,
  • Nicola Susca,
  • Afshin Derakhshani,
  • Paolo Ditonno,
  • Carolina Terragna,
  • Michele Cavo and
  • Vito Racanelli
  • + 6 authors+ 1 author

25 March 2023

Growing evidence suggests a role for peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in the angiogenesis, growth, and metastasis of solid tumors, but little is known about its role in multiple myeloma (MM). Angiogenesi...

(This article belongs to the Collection Emerging Topics in Vascular Endothelial Cell Biology)
  • Article
  • Open Access
8 Citations
3,983 Views
17 Pages

The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells

  • Carmen Ciavarella,
  • Ilenia Motta,
  • Francesco Vasuri,
  • Teresa Palumbo and ,
  • Anthony Paul Lisi,
  • Alice Costa,
  • Annalisa Astolfi,
  • Sabrina Valente,
  • Piera Versura and
  • Gianandrea Pasquinelli
  • + 8 authors+ 3 authors

23 February 2023

The failure of arteriovenous fistulas (AVFs) following intimal hyperplasia (IH) increases morbidity and mortality rates in patients undergoing hemodialysis for chronic kidney disease. The peroxisome-proliferator associated receptor (PPAR-γ) may...

(This article belongs to the Special Issue Molecular Studies on Tissue-Specific Endothelial Cells in Development, Homeostasis and Disease 2.0)
  • Article
  • Open Access
40 Citations
4,896 Views
15 Pages

PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2

  • Leandro Ceotto Freitas-Lima,
  • Alexandre Budu,
  • Adriano Cleis Arruda,
  • Mauro Sérgio Perilhão and ,
  • Jonatan Barrera-Chimal,
  • Ronaldo Carvalho Araujo and
  • Gabriel Rufino Estrela
  • + 2 authors+ 0 author

8 October 2020

Cisplatin is a chemotherapy drug widely used in the treatment of solid tumors. However, nephrotoxicity has been reported in about one-third of patients undergoing cisplatin therapy. Proximal tubules are the main target of cisplatin toxicity and cellu...

(This article belongs to the Special Issue Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations)
  • Article
  • Open Access
1 Citations
3,576 Views
14 Pages

The Influence of FAM13A and PPAR-γ2 Gene Polymorphisms on the Metabolic State of Postmenopausal Women

  • Bogna Grygiel-Górniak,
  • Iwona Ziółkowska-Suchanek,
  • Lidia Szymkowiak,
  • Natalia Rozwadowska and
  • Elżbieta Kaczmarek

14 April 2023

Recently, we have observed two significant pandemics caused by communicable (COVID-19) and non-communicable factors (obesity). Obesity is related to a specific genetic background and characterized by immunogenetic features, such as low-grade systemic...

(This article belongs to the Special Issue New Advances in Immunogenetics of Disease)

of 32